NCT01123018

Brief Summary

We hope to recruit participants into various clinical trials and research projects.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Jun 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jun 2007Dec 2029

Study Start

First participant enrolled

June 1, 2007

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 13, 2010

Completed
19.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

22.5 years

First QC Date

May 11, 2010

Last Update Submit

April 25, 2022

Conditions

Memory LossMemory DeficitsDementia

Keywords

Memory Loss

Study Arms (1)

Older Adults

Persons over age 60 Participants will complete the Memtrax memory screening test

Behavioral: Memtrax Memory screening test

Interventions

Memtrax Memory screening testBEHAVIORAL

Memory Screening test

Also known as: Memory screening
Older Adults

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

healthy older adults with memory concerns

You may qualify if:

  • Age 55 or over.

You may not qualify if:

  • Major psychiatric problems.
  • Major medical problems.
  • Aversion to test-taking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto Health Care System

Palo Alto, California, 94304, United States

Location

Related Publications (1)

  • Ashford JW, Borson S. Primary care screening for dementia and mild cognitive impairment. JAMA. 2008 Mar 12;299(10):1132-3; author reply 1133-4. doi: 10.1001/jama.299.10.1132-b. No abstract available.

    PMID: 18334685RESULT

MeSH Terms

Conditions

Memory DisordersDementia

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBrain DiseasesCentral Nervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • J. Wesson Ashford Jr., MD, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
OTHER
Sponsor Type
FED
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

May 11, 2010

First Posted

May 13, 2010

Study Start

June 1, 2007

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

April 27, 2022

Record last verified: 2022-04

Locations

US(1)